This is the authors' abstract. We don't add key points for this paper.
Our findings indicate that renal function is an important covariate for both meropenem pharmacokinetics parameters and target attainment. The target attainment between standard and non-standard dosing group was not comparable. Therefore, therapeutic drug monitoring is indispensable in the dosing adjustment for critically ill patients if it is available.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Gan et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: